The IGF system in thyroid cancer: new concepts

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• The insulin-like growth factor (IGF) system, particularly the type I IGF receptor (IGF-I-R), is implicated in cancer progression and apoptosis resistance.
• Strategies targeting IGF-I-R are common, but the IGF system's complexity suggests other receptors are involved.

Purpose of the Study:

• To investigate the complexity of the IGF system in thyroid cancer.
• To analyze the production and receptor expression of IGF-I and IGF-II in thyroid tumors.

Main Methods:

• Quantification of IGF-I and IGF-II production in malignant and normal thyroid tissues.
• Assessment of IGF-I receptor (IGF-I-R) and insulin receptor (IR) expression across various thyroid cancer histotypes.
• Analysis of IR/IGF-I-R hybrid formation and the relative abundance of IR isoform A (IR-A).

Main Results:

• IGF-I and IGF-II are locally produced in thyroid cancer tissues at higher levels than in normal tissues.
• IGF-I-Rs are overexpressed in differentiated papillary carcinomas, while IRs are significantly overexpressed in all thyroid cancer histotypes.
• High levels of IR/IGF-I-R hybrids and IR-A are present in all thyroid cancer types, indicating their role in IGF-I signaling.

Conclusions:

• The insulin receptor (IR) and IR/IGF-I-R hybrids, along with IR-A, are key players in the overactivation of the IGF system in thyroid cancer.
• These findings highlight the crucial role of IR and its variants in mediating IGF-I mitogenic signaling in thyroid tumors.
• Understanding this complex IGF signaling network is vital for developing targeted thyroid cancer therapies.